Primary Device ID | M71389122049663SAM1 |
NIH Device Record Key | 452f19bf-4491-4777-ae73-24514dbe4f5b |
Commercial Distribution Discontinuation | 2022-06-01 |
Commercial Distribution Status | Not in Commercial Distribution |
Brand Name | Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe |
Version Model Number | FID185704 |
Catalog Number | FID185704 |
Company DUNS | 428453013 |
Company Name | FIDIA FARMACEUTICI SPA |
Device Count | 2 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | true |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us | |
Phone | 866-749-2542 |
customerservice@fidiapharma.us |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Total Volume | 3 Milliliter |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Storage Environment Temperature | Between 2 Degrees Celsius and 25 Degrees Celsius |
Device Issuing Agency | Device ID |
---|---|
HIBCC | M71389122049663SAM0 [Unit of Use] |
HIBCC | M71389122049663SAM1 [Primary] |
MOZ | Acid, Hyaluronic, Intraarticular |
Steralize Prior To Use | false |
Device Is Sterile | true |
Public Version Status | Update |
Device Record Status | Published |
Public Version Number | 4 |
Public Version Date | 2022-09-16 |
Device Publish Date | 2017-02-12 |
M713891220724200 - Hyalgan® Sodium Hylauronate Pre-filled Syringe - 2mL | 2023-10-24 Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL syringe is indicated for the treatment of pain in osteoarthritis (OA) of the |
M713891220724120 - Hyalgan® Sodium Hyaluronate 2mL Vial | 2023-09-21 Hyalgan® Sodium Hylauronate (20mg/2mL) in the 2mL vial is indicated for the treatment of pain in osteoarthritis (OA) of the kne |
M713494290030100 - Hyalo4 Care Clear Hydrogel, 30g | 2023-06-22 Clear hydrogel wound dressing, 30g, Professional Sample |
M713494290100350 - Hyalo4 Care Clear Hydrogel, 100g | 2023-06-22 Clear hydrogel wound dressing, 100g Tube |
M713494440025080 - Hyalo4 Care Hydrogel, 25g | 2023-06-22 Hydrogel wound dressing, 25g, Professional Sample |
M713494440100350 - Hyalo4 Care Hydrogel, 100g | 2023-06-22 Hydrogel wound dressing, 100g Tube |
M713891220496010 - Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe, 1 pack | 2022-10-04 HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and resi |
M71389122049663SAM1 - Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe | 2022-09-16HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and residence time without chemical crosslinking.The hyaluronan in HYMOVIS® is derived from bacterial fermentation. HYMOVIS® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen). It is given by intra-articular injection in two injections given at weekly intervals. |
M71389122049663SAM1 - Hymovis® High Molecular Weight Viscoelastic Hyaluronan, 24mg/3ml syringe | 2022-09-16 HYMOVIS® is based on an ultra-pure hyaluronan engineered using a proprietary process to increase viscosity, elasticity and resi |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HYMOVIS 79171133 4929840 Live/Registered |
FIDIA FARMACEUTICI S.p.A. 2015-04-20 |
HYMOVIS 77896635 4148241 Live/Registered |
Fidia Farmaceutici SpA 2009-12-18 |